We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Reviewing Remdesivir for COVID-19 Patients Who Don’t Require Supplemental Oxygen
EMA Reviewing Remdesivir for COVID-19 Patients Who Don’t Require Supplemental Oxygen
The European Medicines Agency (EMA) is evaluating remdesivir data submitted by Gilead Sciences to determine whether the antiviral’s indication should be expanded to cover adult COVID-19 patients who don’t need supplemental oxygen.